GL1X · GenesisL1 explorer

MolNFT v1 · #137077 · protein

Crystal structure of human MYT1 kinase domain in complex with pha- 848125

5VD1 · Membrane-associated tyrosine- and threonine-specific CDC2…: “Crystal structure of human MYT1 kinase domain in complex with pha- 848125”. X-ray diffraction, 1 ligand (P48), 4 pockets (best druggability 0.69). MolNFT v1 #137077 on…

PDB
5VD1
Type
protein
Length
295 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Membrane-associated tyrosine- and threonine-specific CDC2- inhibitory kinase
EC
2.7.11.1
UniProt
Q99640
Ligands
P48
Pockets
4 · best druggability 0.69

Structure

x-ray diffraction · 1 distinct chain · 36% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMembrane-associated tyrosine- and threonine-specific CDC2- inhibitory kinase (EC 2.7.11.1)protein29536% helix, 18% strandQ99640

Ligands and binding sites

  • P48 · N,1,4,4-tetramethyl-8-{[4-(4-methylpiperazin-1-yl) phenyl]amino}-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide · ligand · chains A
  • PEG · Di(hydroxyethyl)ether · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14090.690.8145P48
2900.410.7821empty
31200.390.7519empty
4690.270.7218empty

Compared structures

  • 5VD1 · Crystal structure of human MYT1 kinase domain in complex with pha-848125 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q99640 · AlphaFold monomer V2.0 prediction for membrane-associated tyrosine- and… · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.